FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

427682002: Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25micrograms injection solution 0.5mL prefilled syringe (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2662928011 Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25micrograms injection solution 0.5mL prefilled syringe (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2674861015 Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25micrograms injection solution 0.5mL prefilled syringe en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    4735221000005116 difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml Is a difteri- og tetanustoxoider og acellulær kighostevaccine false Inferred relationship Some
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. difterivaccine false Inferred relationship Some
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. kighostevaccine false Inferred relationship Some
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. tetanustoxoid false Inferred relationship Some
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml Has manufactured dose form injektionsvæske false Inferred relationship Some
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Diphtheria toxoid false Inferred relationship Some
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. tetanusvaccine false Inferred relationship Some
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Diphtheria vaccine false Inferred relationship Some
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml Is a Product manufactured as parenteral dose form (product) false Inferred relationship Some
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml Has manufactured dose form Solution for injection false Inferred relationship Some
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml Is a difteri- + kighoste- + tetanusvaccine false Inferred relationship Some
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Some
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. kighostevaccine false Inferred relationship Some 2
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. tetanusvaccine false Inferred relationship Some 3
    difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Diphtheria vaccine false Inferred relationship Some 1

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start